Redeye: Avensia - Solid Q3 – More Cautious Outlook
Redeye retains its positive view of Avensia following a Q3 report matching our forecasts. While the somewhat more cautious outlook is negative, Avensia continues to do well in the soft market. We keep our Base Case and forecasts.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/